Q Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College

发表论文 1 篇

代表论文

• [Combination of anlotinib and irinotecan in the second-line treatment of metastatic colorectal cancer: a multicenter phase 1/2 trial]. (2023 · PubMed)